MX2019005867A - Farmaco terapeutico o farmaco profilactico para nefropatia diabetica. - Google Patents

Farmaco terapeutico o farmaco profilactico para nefropatia diabetica.

Info

Publication number
MX2019005867A
MX2019005867A MX2019005867A MX2019005867A MX2019005867A MX 2019005867 A MX2019005867 A MX 2019005867A MX 2019005867 A MX2019005867 A MX 2019005867A MX 2019005867 A MX2019005867 A MX 2019005867A MX 2019005867 A MX2019005867 A MX 2019005867A
Authority
MX
Mexico
Prior art keywords
drug
diabetic nephropathy
prophylactic
therapeutic
therapeutic drug
Prior art date
Application number
MX2019005867A
Other languages
English (en)
Inventor
Tsujimoto Shunsuke
Shirakura Takashi
Tsubosaka Yoshiki
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Publication of MX2019005867A publication Critical patent/MX2019005867A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un fármaco terapéutico o fármaco profiláctico para nefropatía diabética, dicho fármaco comprende un compuesto representado por la fórmula (I), o una sal aceptada para uso farmacéutico de éste, como ingrediente activo. [Fórmula química 1]. (ver Fórmula).
MX2019005867A 2016-11-28 2017-11-27 Farmaco terapeutico o farmaco profilactico para nefropatia diabetica. MX2019005867A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016229972 2016-11-28
PCT/JP2017/042429 WO2018097294A1 (ja) 2016-11-28 2017-11-27 糖尿病性腎症の治療薬または予防薬

Publications (1)

Publication Number Publication Date
MX2019005867A true MX2019005867A (es) 2019-08-14

Family

ID=62195148

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019005867A MX2019005867A (es) 2016-11-28 2017-11-27 Farmaco terapeutico o farmaco profilactico para nefropatia diabetica.

Country Status (17)

Country Link
US (1) US20190374515A1 (es)
EP (1) EP3545954A4 (es)
JP (2) JP6861726B2 (es)
KR (1) KR20190073473A (es)
CN (1) CN109982697A (es)
AU (1) AU2017364804A1 (es)
BR (1) BR112019008388A2 (es)
CA (1) CA3039890A1 (es)
CL (1) CL2019001421A1 (es)
CO (1) CO2019005512A2 (es)
IL (1) IL266311A (es)
MA (1) MA46909A (es)
MX (1) MX2019005867A (es)
PH (1) PH12019501027A1 (es)
RU (1) RU2735538C1 (es)
TW (1) TW201828939A (es)
WO (1) WO2018097294A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816558B2 (en) * 2005-10-07 2010-10-19 Astellas Pharma Inc. Triarylcarboxylic acid derivative
TWI437986B (zh) * 2008-01-31 2014-05-21 R Tech Ueno Ltd 噻唑衍生物及使用該衍生物作為ｖａｐ－１抑制劑之用途
EP2582812B1 (en) * 2010-06-16 2018-01-24 Takeda Pharmaceuticals U.S.A., Inc. Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
WO2012060308A1 (ja) 2010-11-01 2012-05-10 株式会社 三和化学研究所 腎機能障害の予防又は治療に用いる医薬
TWI548630B (zh) * 2011-04-06 2016-09-11 Ｌｇ生命科學有限公司 １－（３－氰基－１－異丙基－吲哚－５－基）吡唑－４－羧酸結晶型及其製造方法
CN103848796A (zh) * 2012-11-30 2014-06-11 镇江新元素医药科技有限公司(中外合资) 一类氘代2-苯基噻唑化合物及其药物组合物
TWI606048B (zh) * 2013-01-31 2017-11-21 帝人製藥股份有限公司 唑苯衍生物
WO2014140868A2 (en) * 2013-03-15 2014-09-18 Allen Davidoff Xanthine oxidase inhibitor formulations
US20170217948A1 (en) * 2014-07-30 2017-08-03 Teijin Pharma Limited Xanthine oxidase inhibitor

Also Published As

Publication number Publication date
KR20190073473A (ko) 2019-06-26
IL266311A (en) 2019-06-30
CL2019001421A1 (es) 2019-08-30
AU2017364804A1 (en) 2019-05-02
JPWO2018097294A1 (ja) 2019-07-11
US20190374515A1 (en) 2019-12-12
MA46909A (fr) 2021-05-05
RU2735538C1 (ru) 2020-11-03
PH12019501027A1 (en) 2019-12-16
CA3039890A1 (en) 2018-05-31
WO2018097294A1 (ja) 2018-05-31
TW201828939A (zh) 2018-08-16
JP6861726B2 (ja) 2021-04-21
BR112019008388A2 (pt) 2019-07-09
CN109982697A (zh) 2019-07-05
EP3545954A4 (en) 2019-12-04
CO2019005512A2 (es) 2019-07-31
EP3545954A1 (en) 2019-10-02
JP2021028335A (ja) 2021-02-25

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
MX2015003594A (es) Agente terapeutico o profilactico para sindrome de lisis tumoral.
MX2015011913A (es) Moduladores de acido oxabiciclo[2.2.2] gpr120.
MY185491A (en) Macrocylic pyrimidine derivatives
MX366820B (es) Moduladores de gpr120 del acido biciclo[2.2.2].
AU2015211852A1 (en) Heterocyclic sulfonamide derivative and medicine comprising same
MX2017012295A (es) Derivados formilados n-heterociclicos como inhibidores de fgfr4.
PH12016502246A1 (en) Carboxamide derivatives
MX2015015562A (es) Dihidropiridinona como inhibidores de monoacilglicerol aciltransferasa 2.
MX2016014946A (es) Derivados de carboxamida.
PH12018500903A1 (en) Pyranodipyridine compound
NZ731607A (en) Dihydropyrimidin-2- one compounds and medical use thereof
MX2015011375A (es) Moduladores del receptor acoplado a proteina-g 120 (gpr120) de acido biciclo-[2.2.1].
NZ627473A (en) Aryloxyacetamide compound and pesticide
PH12017501404A1 (en) Diaza-benzofluoranthrene compounds
MX2017008074A (es) DERIVADOS DE IMIDAZOPIRIDAZINA COMO INHIBIDORES DE FOSFOINOSITIDA-3-QUINASAS BETA (PI3Kß).
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
EA201691741A1 (ru) Фармацевтическая композиция
MX2017008076A (es) DERIVADOS DE IMIDAZOPIRIDAZINA ENLAZADOS A HETEROCICLILO COMO INHIBIDORES DE PI3Kß.
PH12019501027A1 (en) Therapeutic drug or prophylactic drug for diabetic nephropathy
MX367576B (es) Agente terapéutico o profiláctico para esclerosis múltiple.
PH12016502247A1 (en) Carboxamide derivatives
MX2017000580A (es) Agente profilactico o terapeutico para enfermedades del segmento posterior del ojo.